GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Total Liabilities | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr | ₹4,086 Cr |
What is the latest Total Liabilities ratio of GLAND PHARMA ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹8,778 Cr |
Mar2022 | ₹7,834 Cr |
Mar2021 | ₹6,496 Cr |
Mar2020 | ₹4,086 Cr |
How is Total Liabilities of GLAND PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹8,778 Cr | 12.05 | |
Mar2022 | ₹7,834 Cr | 20.59 | |
Mar2021 | ₹6,496 Cr | 58.98 | |
Mar2020 | ₹4,086 Cr | - |
Compare Total Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹29,510.1 Cr | 0.9% | 1% | 32.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 0.9% |
1% |
32.4% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses